← July 23, 2026 briefing
NHS Approves 'Life-Changing' MS Drug for 5,000 Patients
Health

NHS Approves 'Life-Changing' MS Drug for 5,000 Patients

Fampridine, a drug that boosts nerve signal transmission to improve walking ability in multiple sclerosis patients, has been approved for prescription on the NHS in England. Up to 5,000 people with MS are now eligible for the treatment.

Sources

More from today's briefing

US Bombs Iran for 12th Night, Signs Saudi Nuclear Deal
World

US Bombs Iran for 12th Night, Signs Saudi Nuclear Deal

House Passes $1.15 Trillion Military Bill, Eyes $95 Billion Iran War Fund
Politics

House Passes $1.15 Trillion Military Bill, Eyes $95 Billion Iran War Fund

Tesla Profits Slump as Google Burns $6 Billion on AI
Economy

Tesla Profits Slump as Google Burns $6 Billion on AI

Spain Wildfire Burns 32,000 Hectares, France Also Threatened
Climate

Spain Wildfire Burns 32,000 Hectares, France Also Threatened